Effects of weight loss on metabolic control, blood pressure, carotid intima-media thickness and abdominal fat distribution in obese geriatric women

Obesity and Metabolism

Volumn 6, Issue 2-3, 2010, Pages 50-56

  Varli, Murat ^a   Yagmurlu, Banu ^b   Aras, Sevgi ^a   Atli, Teslime ^a   Erdogan, Gurbuz ^c  

^a ANKARA UNIVERSITY   (Turkey)

^b KIRIKKALE UNIVERSITY   (Turkey)

^c UFUK UNIVERSITY   (Turkey)

Author keywords

Cardiovascular risk factors; Elderly; Insulin resistance; Obesity; Weight loss

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TETRAHYDROLIPSTATIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ABDOMINAL FAT; AGED; ANTHROPOMETRIC PARAMETERS; ARTERIAL WALL THICKNESS; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; BODY FAT DISTRIBUTION; BODY MASS; CARDIOVASCULAR RISK; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; FEMALE; GERIATRIC PATIENT; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LOW CALORY DIET; METABOLIC REGULATION; OBESITY; SUBCUTANEOUS FAT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

EID: 78651332350     PISSN: 18253865     EISSN: 18267572     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Ogden CL, Yanovski SZ, Carroll MD, Flegal KM. The epidemiology of obesity. Gastroenterology 2007; 132:2087-102.
2. Raatz SK, Torkelson CJ, Redmon JB, et al. Reduced glycemic index and glycemic load diets do not increase the effects of energy restriction on weight loss and insulin sensitivity in obese men and women. J Nutr 2005; 135:2387-91.
3. Tong PCY, Lee ZSK, Sea MM, et al. The effects of orlistat-induced weight loss, without concomitant hypocaloric diet, on cardiovascular risk factors and insulin sensitivity in young obese Chinese subjects with or without type 2 diabetes. Arch Intern Med 2002; 162: 2428-35.
4. Pereira JA, Lazarin MACT, Pareja JC, de Souza A, Muscelli E. Insulin resistance in nondiabetic morbidly obese patients: effect of bariatric surgery. Obes Res 2003; 11:1495-501.
5. Hill JO, Hauptman J, Anderson JW, et al. Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study. Am J Clin Nutr 1999; 69:1108-16.
6. Hsieh CJ, Wang PW, Liu RT, et al. Orlistat for obesity: benefits beyond weight loss. Diabetes Res Clin Pract 2005; 67: 78-83. (Pubitemid 40037733)
7. Cnop M, Landchild MJ, Vidal J, et al. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations distinct metabolic effects of two fat compartments. Diabetes 2002; 51: 1005-15. (Pubitemid 34438343)
8. Takami R, Takeda N, Hayashi M, et al. Body fatness and fat distribution as predictors of metabolic abnormalities and early carotid atherosclerosis. Diabetes Care 2001; 24:1248-52.
9. Narkiewicz K. Diagnosis and management of hypertension in obesity. Obesity Rev 2006; 7:155-62.
10. Kotsis V, Stabouli S, Bouldin M, Low A, Toumanidis S, Zakopoulos N. Impact of obesity on 24-hour ambulatory blood pressure and hypertension. Hypertension 2005; 45: 602-7.
11. Meigs JB, Jacoues PF, Selhub J, et al. Fasting plasma homocysteine levels in the insulin resistance syndrome. Diabetes Care 2001; 24:1403-10.
12. Martosa R, Valleb M, Moralesb R, Canetec R, Gaviland MI, Margalet VS. Hyperhomocysteinemia correlates with insulin resistance and low-grade systemic inflammation in obese prepubertal children. Metab Clin Exp 2006; 55: 72-7.
13. Katsuki A, Sumida Y, Gabazza EC, et al. Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes. Diabetes Care 2001; 24: 362-65.
14. McLaughlin T, Allison G, Abbasi F, Lamendola C, Reaven G. Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individuals. Metabolism 2004; 53: 495-9.
15. Villareal DT, Miller BV, Banks M, Fontana L, Sinacore DR, Klein S. Effect of lifestyle intervention on metabolic coronary heart disease risk factors in obese older adults. Am J Clin Nutr 2006; 84:1317-23.
16. Davidson MH, Hauptman J, DiGirolamo M, et al. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat. JAMA 1999; 281:235-42.
17. Hsieh CJ, Wang PW, Liu RT, et al. Orlistat for obesity: benefits beyond weight loss. Diabetes Res Clin Pract 2005; 67: 78-83.
18. Lindgarde F, Hildefors H, Kohlström A, et al. The effect of orlistat on body weight and coronary heart disease risk profile in obese patients: The Swedish multimorbidity study. J Intern Med 2000; 248: 245-54.
19. Mikhail N, Golub MS, Tuck ML. Obesity and hypertension. Progr Cardiovasc Dis 1999; 42:39-58.
20. Bakrisa G, Calhounb D, Eganc B, Hellmannd C, Dolkerd M, Kingmad I. Orlistat improves blood pressure control in obese subjects with treated but inadequately controlled hypertension. J Hypertens 2002; 20: 2257-67.
21. Schillaci G, Pasqualini L, Vaudo G, et al. Effect of body weight changes on 24-hour blood pressure and left ventricular mass in hypertension: a 4-year follow-up. Am J Hypertens 2003; 16: 634-9.
22. Kotsis VT, Stabouli SV, Papamichael CM, Zakopoulos NA. Impact of obesity in intima media thickness of carotid arteries. Obesity 2006; 14:1708-15.
23. Tomita H, Ohtsuka N, Inoue A, Kamitani A. Metabolic syndrome, diabetes and subclinical atherosclerosis as assessed by carotid intima-media thickness. J Atheroscler Thromb 2007; 14: 78-85.
24. Mavri A, Stegnar M, Sentocnik JT, Videcnik V. Impact of weight reduction on early carotid atherosclerosis in obese premenopausal women. Obes Res 2001; 9: 511-6. (Pubitemid 33610171)
25. Karason K, Wikstrand J1 Sjöström L, Wendelhag I. Weight loss and progression of early atherosclerosis in the carotid artery: a four-year controlled study of obese subjects. Int J Obes Relat Metab Disord 1999; 23: 948-56. (Pubitemid 29423938)
26. Hirooka M, Kumagi T, Kurose K, et al. A technique for the measurement of visceral fat by ultrasonography: comparison of measurements by ultrasonography and computed tomography. Intern Med 2005; 44: 794-9. (Pubitemid 41263822)
27. Nicklas BJ, Cesari M, Penninx BWJH, et al. Abdominal obesity is an independent risk factor for chronic heart failure in older people. J Am Geriatr Soc 2006; 54: 413-20.
28. Racette SB, Evans EM, Weiss EP, Hagberg JM, Holloszy JO. Abdominal adiposity is a stronger predictor of insulin resistance than fitness among 50-95 year olds. Diabetes Care 2006; 29:673-8.
29. Sabir N, Pakdemirli E, Semiez Y, Zincir M, Kazil S. Sonographic assessment of changes in thickness of different abdominal fat layers in response to diet in obese women. J Clin Ultrasound 2003; 31:26-30.
30. Purnell JQ, Kahn SE, Albers JJ, Nevin DN, Brunzell JD, Schwartz RS. Effect of weight loss with reduction of intra-abdominal fat on lipid metabolism in older men. J Clin Endocrinol Metab 2000; 85: 977-82.